Yang et al. showed that ALDH+ BCSCs were responsible for cisplatin resistance and the ALDH+ BCSCs displayed higher levels of reactive oxygen species (ROS) from bulk breast cancer cells. The gene discussed is LDHA; the disease is breast carcinoma.